Demet Russ – Managing Director, Janssen Turkey
Janssen’s Managing Director for Turkey, Demet Russ, discusses her return to the country after 25 years abroad,…
Med-Ilac (TEVA) Turkey
Last updated: 13.02.2014
Address: Veko Giz Plaza, Maslak Mah. Maslak Meydanı Sok. No: 3 K: 5-6, Maslak,Turkey
Tel: +90 212 367 9100
Web: http://www.medilac.com.tr/
Company description
Med-Ilac is a Turkish company that represents Teva products (worlds largest generics producer) in Turkey and the region. It is involved in Registration, Sales & Marketing of Teva products.
Products and services
Products cover a wide range of pharaceutical area’s including Central Nervous System, respiratory, woman’s health, pain management and oncology.
Related
Philipp Haas – Chairman of BOD & CEO, DEVA
As one of the leading pharma companies in Turkey, DEVA is pioneering a new approach to generics in the country.…
Turkey / A Moment of Reckoning on Diabetes?
As COVID-19 began spreading through the world, the race to understand the disease by scientists and doctors took…
Mustafa Kemal – President, Turkish Society of Cardiology
The president of the Turkish Society of Cardiology, Mustafa Kemal Erol, discusses the prevalence of cardiovascular…
Asli Özelli – Executive Director, AmCham Turkey
AmCham Turkey’s executive director, Asli Özelli, examines the impact of US companies on the Turkish economy with…
Burak Cem – VP & General Manager, Novo Nordisk Turkey
Dr Burak Cem, Novo Nordisk Vice President and General Manager for Turkey, outlines the company’s big bet on…
Bülent Akarcali – Chairman, NBA Consulting, Turkey
Turkey’s former Minister of Health, Bülent Akarcali, outlines the country’s healthcare system evolution over…
Turkey / Koçak Farma & The Push for Homegrown COVID-19 Vaccines
As the international community continues its quest to vaccinate the global population against COVID-19, shortages…
Ümit Dereli – Secretary General, AIFD, Turkey
Ümit Dereli is secretary general of the Turkish Association of Research-Based Pharmaceutical Companies (AIFD),…
Turkey / Abdi Ibrahim Buys 28.5% Stake in Swiss OM; A Historic Moment for Turkish Pharma
When Abdi Ibrahim acquired a 28.5 percent stake in Swiss biotech OM Pharma in September 2020, it represented a…
Company Spotlight / Acıbadem's Grand Ambitions
There is perhaps no Turkish company in the healthcare sector that is more ambitious than Acıbadem. Not only has…
Pharma Faces / Ferhat Farsi, Cinnagen
Dr Ferhat Farsi, CEO and founding partner of CinnaGen İlaç, shares his experience working for the largest biotech…
